Artificial Pancreas

(redirected from Bioartificial Pancreas)
Also found in: Wikipedia.
An insulin delivery device designed to control glucose levels and optimally deliver insulin to a patient whose islet cells don’t secrete enough insulin
References in periodicals archive ?
MAILPAN (MAcroencapsulation of PANcreatic Islets) is a prototype of bioartificial pancreas usable in the human designed to treat type 1 diabetic patients.
The project proposal of a 36-month duration intends to bring the most modern and up to date improvements that the bioartificial pancreas still needs and can receive such as to enhance cells survival inside the device by formulating a new adapted cell culture medium, to further lower the rejection risk by studying the biocompatibility and anti-inflammatory mechanisms, to test the prototype in primates, and to validate its further use in humans.
The authors' aim in this work is to correct diabetes by the use of a bioartificial pancreas (BAP).
a leader in the research and development of a bioartificial pancreas, a minimally invasive cellular transplant for the treatment of insulin-dependent diabetes mellitus, has obtained exclusive rights for diabetes cell therapy from the University of Texas to United States Patent Number 5,529,914, issued on June 25, 1996.
BUSINESS WIRE)--March 13, 1995--Neocrin Company, a biomedical company developing a bioartificial pancreas for treatment of insulin-dependent diabetes, announced that it has raised $12.
Neocrin is a leader in the research and development of a bioartificial pancreas, a minimally invasive implantable device, to treat insulin-dependent diabetes.
We believe our approach, while radically different from others, offers the real potential for developing an effective bioartificial pancreas," Woodward said.
Together, the "stealth" polymer and the hydrogel matrix form an implantable bioartificial pancreas that in pre-clinical trials successfully produces insulin in animals.
NYSE: GRA) today announced that it will commence human Phase I clinical trials of its BioArtificial Pancreas to determine the safety and tolerability of the implant in diabetic patients.
Our ultimate goal is to demonstrate that the BioArtificial Pancreas can help patients suffering from insulin-dependent diabetes lead more normal lives and minimize some of the complications associated with diabetes," said Dr.
a biomedical company developing a bioartificial pancreas for the treatment of insulin-dependent diabetes, announced today the appointment of Thomas P.
Development efforts are currently concentrated on the bioartificial pancreas, an implantable device capable of regulating blood glucose levels over sustained periods.